Preclinical toxicologic evaluation of nadolol, a new β-adrenergic antagonist
- 1 May 1978
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 44 (2) , 379-389
- https://doi.org/10.1016/0041-008x(78)90198-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Metabolic Studies in Patients with Nadolol: Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1977
- Nadolol: Placental transfer and excretion in the milk of ratsToxicology and Applied Pharmacology, 1977
- Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depressionEuropean Journal of Pharmacology, 1975
- Effect of some β-adrenoceptor blocking drugs on insulin secretion in the ratJournal of Pharmacy and Pharmacology, 1974
- EFFECT OF ADRENERGIC BLOCKING AGENTS ON INSULIN RESPONSE TO GLUCOSE INFUSION IN MANActa Endocrinologica, 1972
- TOLBUTAMIDE AND PROPRANOLOLThe Lancet, 1968
- THE EFFECT OF ADRENERGIC RECEPTOR BLOCKING DRUGS ON THE HUMAN UTERUSBJOG: An International Journal of Obstetrics and Gynaecology, 1968
- Experiments with pharmacologic sympatholysis in the gravidAmerican Journal of Obstetrics and Gynecology, 1967